Cerephex to seek FDA clearance for fibromyalgia treatment

06/3/2010 | Medical Devices Today

Cerephex said it will submit an application with the FDA within a year to seek 510(k) clearance for NeuroPoint, a non-invasive device that delivers cortical stimulation to treat fibromyalgia. The company plans to schedule a July meeting with the agency to ask for comments on its two-year study data.

View Full Article in:

Medical Devices Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA